Jon Jones has signed his first major endorsement since his return to UFC competition, partnering with an undisclosed brand while sports nutrition company Xyience simultaneously renewed contracts with five additional mixed martial arts athletes. The twin announcements mark the first formal read on sponsor confidence in combat sports talent after eighteen months of static deal flow.
Jones, 32, has competed twice since his August 2020 reinstatement following a 15-month USADA suspension. His heavyweight debut at UFC 285 drew 650,000 pay-per-view buys, the third-highest gate in promotional history. The endorsement—his first since losing deals with Nike, Gatorade, and MuscleTech between 2015 and 2017—comes three weeks before his scheduled title defense against Stipe Miocic. Terms were not disclosed. Jones previously earned an estimated $2.8 million annually from endorsements at his 2013 peak, per Forbes reconstructions.
Xyience, acquired by Big Red in 2017 after a bankruptcy filing, has held fighter rosters between eight and twelve athletes since the energy-drink wars cooled in 2019. The five renewals—names not released—suggest the brand is treating MMA as a sustained allocation rather than an opportunistic play. Xyience's previous roster included former champions who continued earning mid-five-figure annual retainers even after title losses, a structure rare in combat sports where most deals include automatic termination clauses tied to ranking.
The timing matters for two reasons. First, UFC's new $335 million annual media rights deal with ESPN creates downstream value for fighter sponsorships by stabilizing viewership floors; brands now buy against a 600,000-viewer guarantee rather than the 200,000-to-900,000 range that prevailed under Fox. Second, Venum's $12 million annual UFC uniform deal expires in December 2024, and rival apparel brands are already conducting fighter surveys to map post-Venum roster strategies. An athlete with a standing endorsement has leverage in those negotiations that an unattached fighter does not.
Jones's deal is the first test of whether sponsors will pay for redemption narratives or demand multi-year clean records. His case is unusually complex: three failed drug tests, two overturned results, one plea agreement for a hit-and-run, and one arrest for domestic battery that resulted in no charges. But his 27-1 record and status as the only active fighter to have held the light heavyweight title for more than 1,500 days gives him a floor that mid-tier athletes lack. If the deal includes performance bonuses tied to title defenses or pay-per-view thresholds, it will become the template for other comeback-stage athletes.
Xyience's move is less ambiguous. The brand has survived two ownership changes and a bankruptcy by treating MMA as a cost-stable channel: five-figure annual retainers, social-media obligations, and no broadcast integration requirements. That model works when athlete turnover is predictable and the brand's customer base—18-to-34-year-old men in Sun Belt gyms—overlaps cleanly with UFC's core demo. Renewals rather than new signings suggest Xyience is defending share, not expanding it.
Watch whether Jones's partner announces within the next ten days; UFC 285 media obligations begin March 26, and brands typically sync reveals with fight-week coverage. Xyience will likely name its five athletes before the April 15 UFC pay-per-view in Jacksonville, where three of its previous roster members are scheduled to compete. And monitor whether Venum's uniform renewal enters formal negotiation before June; if it does, expect a wave of fighter endorsements as apparel brands position for post-deal roster raids.
Jones's deal proves sponsors are willing to pay for active fighters with baggage. Xyience's renewals prove they will pay more to keep them.